Indications for Use:

Respicomb^® Air is indicated for use in adult patients (18 years and older) for:

• Maintenance therapy of bronchial asthma requiring combination therapy (inhaled glucocorticosteroid (ICS) and long-acting beta2-adrenergic agonist):
  • In patients whose asthma symptoms are not adequately controlled with inhaled ICS and short-acting beta2-adrenergic agonists.
  • In patients who are already receiving effective maintenance doses of inhaled ICS and long-acting beta2-adrenergic agonists.
• Treatment of bronchial obstruction in patients with severe chronic obstructive pulmonary disease (COPD) (FEV1 less than 50% of the predicted normal value) who continue to have significant symptoms despite regular bronchodilator therapy.

Included in the List of Essential Medicines